Corcept Therapeutics Incorporated (NASDAQ:CORT) Given Average Rating of “Buy” by Brokerages
Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) have earned a consensus rating of “Buy” from the five ratings firms that are covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a buy rating. The average 12 month price target among brokers that have covered the stock in […]
Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) have earned a consensus rating of “Buy” from the five ratings firms that are covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a buy rating. The average 12 month price target among brokers that have covered the stock in […]
